LINC00869
Putative uncharacterized protein encoded by LINC00869
Also known as: F91A2_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for LINC00869 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
280 residues, UniProt reviewed canonical sequence.
>P0C866|LINC00869
1 MLLSWGGGES RRPVQEASSA TDTDTNSQED PADTASVRSL SLSAGHTKHI AFLFDSTLTA
61 FLMMGNLSPV QSTGEREAQR YFEHALTLRN TTLFLRHNKD LVVQTAQPDQ PNYGFPLDLL
121 RCESLLGLDP ATGSRVLNKN YTLLVSMAPL TNEIRPVSSC TPQHIGPAIP EVSSVWFKQY
181 IYVYHITGQG PPSLLLSKGT RPRKLPDIFQ SYDRLLITSW GHDPGVVPTS NVLTMLNDAL
241 THSAVLIQEH GLHGIGETVH VPFPFDETEL QEDSCQYGCSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LINC00869 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LINC00869 as an antibody target. Whether an autoantibody or antibody against LINC00869 could matter depends on whether native LINC00869 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LINC00869 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LINC00869 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...